Neurobiology and Clinical Neuroscience
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Diagnostic Biomarkers and Novel Therapeutics Targets for Fragile X Syndrome, Autism Spectrum Disorders and Genetic Neurodevelopmental Diseases: Advances and Challenges, 2nd Edition (Deadline: 31 July 2026)
- State of the Art on Demyelinating Diseases in Latin America (Deadline: 31 July 2026)
- Pathogenesis and Therapeutic Intervention of Alzheimer's Disease (Deadline: 31 July 2026)
- Multiple Sclerosis: Neuro-Technology and New Approaches for Treatment, Diagnosis and Symptom Monitoring (Deadline: 31 July 2026)
- Clinical Genetics and Genomics of Neurodegenerative Diseases (Deadline: 31 July 2026)
- Neuroinflammation: From Mechanisms to Therapeutic Approaches (Deadline: 31 July 2026)
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management—2nd Edition (Deadline: 31 July 2026)
- Advanced Research in Neuroprotection: 2nd Edition (Deadline: 31 July 2026)
- Animal Models of Neurological Disorders: Where Are We Now? (3rd Edition) (Deadline: 31 July 2026)
- Brain Injury: New Insights into Mechanisms and Future Promising Treatments—Second Edition (Deadline: 31 July 2026)
- Traumatic CNS Injury: From Bench to Bedside (2nd Edition) (Deadline: 31 July 2026)
- Molecular Mechanisms and Novel Therapies for Brain Injury: 3rd Edition (Deadline: 30 August 2026)
- Advanced Research in Biomarkers of Neurodegenerative Disorders (Deadline: 31 August 2026)
- Insights into Retinal Development, Disease, and Neuroprotection with Pharmacologic and Perioperative Considerations (Deadline: 31 August 2026)
- Multiple Sclerosis: Diagnosis and Treatment—3rd Edition (Deadline: 31 August 2026)
- Current Challenges and Future Trends in Intracranial Aneurysms: Mechanisms, Biomarkers, and Therapeutic Strategies (Deadline: 31 August 2026)
- New Advances in Neuroprotective Agents (Deadline: 31 August 2026)
- Cell Metabolism in Brain Physiology and Pathology: From Molecular Mechanisms to Therapeutic Targets (Deadline: 31 August 2026)
- Exploring Neuroinflammation in Central and Peripheral Neuropathic Pain and Related Disorders (Deadline: 31 August 2026)
- Precision Diagnosis, Novel Mechanisms and Targeted Therapy for Autoimmune Encephalitis (Deadline: 31 August 2026)
- Molecular Mechanisms of Neurotoxicity and the Discovery of Neuroprotective Agents (Deadline: 30 September 2026)
- Multiple Sclerosis: From Diagnosis to Personalized Treatment Strategies (Deadline: 30 September 2026)
- Advances in Neurological Diseases: Pathogenesis, Diagnosis and Therapeutic Strategies (2nd Edition) (Deadline: 30 September 2026)
- The Peripheral Nervous System: Morphology and Function (Deadline: 30 September 2026)
- The Prefrontal Cortex in Cognition and Diseases (Deadline: 30 September 2026)
- New Approaches to Spinal Cord-Related Diseases (Deadline: 30 September 2026)
- Nervous System Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 September 2026)
- Emerging Research in Neurorehabilitation, 2nd Edition (Deadline: 30 September 2026)
- Neural Organoids: Advancing Our Understanding of the Central and Peripheral Nervous Systems (Deadline: 30 September 2026)
- Neural Nexus: Interdisciplinary Perspectives on Neurological Disorders (Deadline: 30 September 2026)
- Parkinson’s Disease: Where Are We and Where Are We Going To (Deadline: 30 September 2026)
- Parkinson’s Disease: From Pathogenesis to Biomarkers and Therapeutic Strategies (Deadline: 30 September 2026)
- Gut–Brain Axis in Neuropsychiatric and Neurodegenerative Disorders (Deadline: 30 October 2026)
- Neurotransmitter Signaling in Central Nervous System Diseases: Mechanisms, Biomarkers and Therapeutic Targets (Deadline: 30 October 2026)
- Immune and Metabolic Dysregulation in Neurological and Neuropsychiatric Disorders (Deadline: 31 October 2026)
- Crosstalk Between Depression, Anxiety, Dementia, and Chronic Pain Comorbidity in Behavioral Neurology and Neuropsychiatry—4th Edition (Deadline: 31 October 2026)
- Dopamine in Health and Disease (3rd Edition) (Deadline: 31 October 2026)
- Neuroimmunology and Neurological Infection (Deadline: 31 October 2026)
- Nervous System Injury and Repair: From Molecular Mechanism to Therapeutic Perspectives (Deadline: 31 October 2026)
- Multidisciplinary Approaches to Neurodegenerative Disorders (Deadline: 31 October 2026)
- Targeting Ferroptosis in Neurological Diseases (Deadline: 31 October 2026)
- Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches, 2nd Edition (Deadline: 31 October 2026)
- Demyelinating Diseases: Pathophysiology and Emerging Therapeutic Targets (Deadline: 31 October 2026)
- Neurovascular Dysfunction: Mechanisms and Therapeutic Strategies (Deadline: 31 October 2026)
- Multimodal Brain Imaging in Clinical Practice (Deadline: 30 November 2026)
- Cellular and Molecular Biology of Neurodegenerative Disorders, 2nd Edition (Deadline: 30 November 2026)
- Brain Disorders: Bridging Molecular Insights and Innovative Therapies (Deadline: 30 November 2026)
- Advances in Biomarkers for Neurodegenerative Diseases: From Molecular Discovery to Early Diagnosis (Deadline: 30 November 2026)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (3rd Edition) (Deadline: 30 November 2026)
- Neural Plasticity: Mechanisms and Therapeutic Implications (Deadline: 30 November 2026)
- Encephalitis and Viral Infection: Mechanisms and Therapies—2nd Edition (Deadline: 30 November 2026)
- Imaging and Modeling Alzheimer's Disease: The Quest for Mechanistic Understanding, Early Diagnosis, and Novel Treatments (Deadline: 30 November 2026)
- Fibromyalgia and Neuroinflammation: Unraveling Pathophysiological Links and Therapeutic Targets (Deadline: 30 November 2026)
- Pathogenesis and Treatment of Amyotrophic Lateral Sclerosis (ALS) (Deadline: 31 December 2026)
- Neuro-Orthopaedics: Neural Injury, Pain, and Functional Recovery in Musculoskeletal Disorders (Deadline: 31 December 2026)
- Gene- and Peptide-Based Therapeutics for Neurodegenerative Disorders (Deadline: 31 December 2026)
- Neuroinflammation and Brain Clearance Systems: Therapeutic Frontiers in Neurodegenerative Diseases (Deadline: 31 December 2026)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases: 2nd Edition (Deadline: 22 January 2027)
- The Tryptophan Metabolic Axis and Neuropeptide Networks: Translational Frontiers in Psychiatry and Neurodegeneration (Deadline: 31 January 2027)
- Gliomas: Signaling Pathways, Molecular Mechanisms and Novel Treatment (Deadline: 31 January 2027)
- Alzheimer's Disease: Mechanisms, Pathology and Precision Therapy (Deadline: 28 February 2027)
- Multiple Sclerosis: From Early Diagnosis to Personalized Therapeutic Approaches (Deadline: 28 February 2027)
- Advances in Parkinson’s Disease Research (Deadline: 28 February 2027)
- Artificial Intelligence Applications in Neuroscience and Brain Diseases (Deadline: 28 February 2027)
Topical Collections
Following topical collections within this section are currently open for submissions:
